Form 4 for OMDA Omada Health, Inc.
Accepted 2026-07-08 20:14:07 ET · period of report 2026-07-01 · accession 0001610717-26-000327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-08 20:14 | 2026-07-01+ | OMDA | Cook Steven L. | CFO | M - OptEx | $8.26 | +35.6K | 199.5K | +22% | +$294.1K |
| DMT | 2026-07-08 20:14 | 2026-07-01+ | OMDA | Cook Steven L. | CFO | S - Sale+OE | $22.87 | -35.6K | 187.2K | -16% | -$814.3K |
| DMT | 2026-07-08 20:14 | 2026-07-01+ | OMDA | Cook Steven L. | CFO | M - OptEx | $0.00 | -35.6K | 21.5K | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | M | A | 23,263 | $8.28 | 210,472 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-01 | S | D | 23,263 | $22.76 | 187,209 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $22.11 to $23.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-07-07 | M | A | 10,601 | $8.28 | 197,810 | D | — | — | |
| 4 | Common | Common Stock | 2026-07-07 | M | A | 1,042 | $8.01 | 198,852 | D | — | — | |
| 5 | Common | Common Stock | 2026-07-07 | M | A | 694 | $7.68 | 199,546 | D | — | — | |
| 6 | Common | Common Stock | 2026-07-07 | S | D | 12,337 | $23.09 | 187,209 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $23.00 to $23.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 23,263 | $0.00 | 278,246 | D | $8.28 · — to 2031-07-19 | 23,263 Common Stock | (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-07-07 | M | D | 10,601 | $0.00 | 267,645 | D | $8.28 · — to 2031-07-19 | 10,601 Common Stock | (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-07-07 | M | D | 1,042 | $0.00 | 19,792 | D | $8.01 · — to 2034-02-08 | 1,042 Common Stock | (F5) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-07-07 | M | D | 694 | $0.00 | 21,528 | D | $7.68 · — to 2035-01-27 | 694 Common Stock | (F6) 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |